PLRX icon

Pliant Therapeutics

55 hedge funds and large institutions have $635M invested in Pliant Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 11 closing their positions.

Holders
55
Holders Change
+18
Holders Change %
+48.65%
% of All Funds
1.11%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
29
Increased
7
Reduced
9
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Citigroup
51
Citigroup
New York
$11K +$11K +500 New
CAW
52
Cornerstone Advisors (Washington)
Washington
$1K +$1K +42 New
Millennium Management
53
Millennium Management
New York
$388 -$1.2K -52,920 -76%
SCM
54
Suvretta Capital Management
New York
-$3.07M -94,700 Closed
ZP
55
Zimmer Partners
New York
-$2.78M -85,741 Closed
PAMU
56
Pictet Asset Management (UK)
United Kingdom
-$2.6M -80,000 Closed
Goldman Sachs
57
Goldman Sachs
New York
-$1.46M -45,000 Closed
MWNA
58
Marshall Wace North America
New York
-$1.26M -38,825 Closed
MIM
59
Monashee Investment Management
Massachusetts
-$1.17M -36,000 Closed
DKCM
60
Davidson Kempner Capital Management
New York
-$772K -24,000 Closed
Jane Street
61
Jane Street
New York
-$435K -13,389 Closed
MS
62
Maven Securities
Jersey
-$253K -7,800 Closed
EC
63
EcoR1 Capital
California
-$42K -1,300 Closed
PCM
64
Pinz Capital Management
New York
-$16K -500 Closed